↓ Skip to main content

Dove Medical Press

Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

Overview of attention for article published in OncoTargets and therapy, June 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
2 X users
patent
3 patents
facebook
1 Facebook page

Citations

dimensions_citation
243 Dimensions

Readers on

mendeley
247 Mendeley
Title
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Published in
OncoTargets and therapy, June 2014
DOI 10.2147/ott.s60114
Pubmed ID
Authors

Dinesh Vyas, Gieric Laput, Arpitak K Vyas

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 247 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 246 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 40 16%
Student > Master 37 15%
Student > Bachelor 35 14%
Researcher 25 10%
Student > Postgraduate 10 4%
Other 38 15%
Unknown 62 25%
Readers by discipline Count As %
Medicine and Dentistry 47 19%
Biochemistry, Genetics and Molecular Biology 40 16%
Agricultural and Biological Sciences 20 8%
Immunology and Microbiology 13 5%
Pharmacology, Toxicology and Pharmaceutical Science 13 5%
Other 40 16%
Unknown 74 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2024.
All research outputs
#4,759,367
of 25,371,288 outputs
Outputs from OncoTargets and therapy
#210
of 3,016 outputs
Outputs of similar age
#43,555
of 240,960 outputs
Outputs of similar age from OncoTargets and therapy
#5
of 24 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,960 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.